Preview

Rational Pharmacotherapy in Cardiology

Advanced search

TRANSCATHETER AORTIC VALVE IMPLANTATION. STATE OF THE PROBLEM AND PROSPECTS IN RUSSIA

https://doi.org/10.20996/1819-6446-2015-11-1-53-59

Full Text:

Abstract

Nowadays aortic stenosis is the most common valvular pathology in Europe and North America and its incidence increases with age. Long asymptomatic period, the duration of which varies in different patients, is the main clinical feature of this disease. In 80% of asymptomatic patients with the severe aortic stenosis the onset of clinical signs that significantly worsen the prognosis, occurs within the next 4 years. So, if two-year survival rate in asymptomatic period is at least 50%, a 5-year survival rate in patients with symptomatic aortic stenosis without surgery, according to some estimates, is reduced to 15%. Therefore, these patients do not have any alternative to surgery. At that, high risk of complications after surgery and perioperative mortality related to them are the most essential problems of surgical treatment of the aortic valve diseases in the setting of cardiopulmonary bypass. This was the decisive factor for the development of alternative methods of surgical correction of the aortic valve diseases. Indications and contraindications for transcatheter aortic valve implantation (TAVI), which is currently a "disruptive technology", are discussed. Different models of aortic valve prostheses, the use of which is confirmed by the available evidence, are considered. The most important unsolved problems of TAVI use in recent times are mentioned in brief. More than 300 TAVI procedures have been performed in Russia recently which definitely does not cover the actual needs.

About the Authors

T. E. Imaev
Russian Cardiology Research and Production Complex
Russian Federation

Tretya Cherepkovskaya ul. 15a, Moscow, 121552 Russia



A. E. Komlev
Russian Cardiology Research and Production Complex
Russian Federation

Tretya Cherepkovskaya ul. 15a, Moscow, 121552 Russia



R. S. Akchurin
Russian Cardiology Research and Production Complex
Russian Federation

Tretya Cherepkovskaya ul. 15a, Moscow, 121552 Russia



References

1. Andreev E.M, Kvasha E, Har'kova T. Life expectancy in Russia: recovery growth. Demoscope 2014; 621. Available at: http://demoscope.ru/weekly/2014/0621/tema01.php#_ftn1. Checked 02/07/2015. Russian (Андреев Е.М, Кваша Е, Харькова Т. Продолжительность жизни в России: восстановительный рост. Демоскоп 2014; 621. Доступно на: http://demoscope.ru/weekly/2014/0621/tema01.php#_ftn1. Проверено 07.02.2015)

2. Heidenreich P.A., Trogdon J.G., Khavjou O.A., et al. Forecasting the Future of Cardiovascular Disease in the United States A Policy Statement From the American Heart Association. Circulation 2011;123:933-44.

3. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43.

4. Roberts W.C., Ko J.M. Frequency by decades of unicuspid, bicuspid and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis with or without associated aortic regurgitation. Circulation 2005;111:920-5.

5. Nkomo V.T., Gardin J.M., Skelton T.N., et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.

6. Waller B.F., Howard J., Fess S. Pathology of aortic valve stenosis and pure aortic regurgitation: A clinical morphologic assessment. Clin Cardiol 1994;17:85.

7. Pomerance A. The pathogenesis of aortic stenosis in its relation to age. Br Heart J 1972;34:569.

8. Fedak P.W.M., Verma S., David T.E., et al. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002;106:900-4.

9. Liu F.Z., Xue Y.M., Liao H.T., et al. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China. J Thorac Dis 2014;6(12):1724-30.

10. Rosenhek R., Binder T., Porenta G., et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-7.

11. Otto C.M., Burwash I.G., Legget M.E., et al. Prospective study of asymptomatic valvular aortic stenosis clinical, echocardiographic and exercise predictors of outcome. Circulation 1997;95:2262-70.

12. Pellikka P.A., Sarano M.E., Nishimura R.A., et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-5

13. Rosenhek R., Zilberszac R., Schemper M., et al. Natural history of very severe aortic stenosis. Circulation 2010;121:151-6.

14. Chambers J., Bach D., Dumesnil J., et al. Crossing the aortic valve in severe aortic stenosis: no longer acceptable? J Heart Valve Dis 2004;13:344-6.

15. Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.

16. Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148.

17. Baumgartner H., Hung J., Bermejo J., et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiography 2009;10:1-25.

18. Minners J., Allgeier M., Gohlke-Baerwolf C., et al. Inconsistencies of echocardiographic criteria for grading of aortic valve stenosis. Eur Heart J 2008;29:1043-8.

19. Ross J., Braunwald E. Aortic Stenosis. Circulation 1968;38:61-7.

20. Petrovskij B.V., Solov'ev G.M., Shumakov V.I. Prosthetic heart valves. Moscow: Medicina; 1966. Russian (Петровский Б.В., Соловьев Г.М., Шумаков В.И. Протезирование клапанов сердца. М: Медицина; 1966)

21. Hufnagel СA, Harvey WP. Aortic plastic valvular prosthesis. Bull Georgetown Univ Med Center 1952; 4: 1

22. Kolesnikov SA, Cukerman GI, Golikov GT, et al. Experience of using artificial tricuspid valve in the surgical treatment of aortic insufficiency. Grudnaja Hirurgia 1964;5:3-8. Russian (Колесников С. А., Цукерман Г. И., Голиков Г. Т. и др. Опыт применения искусственного трехстворчатого клапана при хирургическом лечении аортальнойнедостаточности. Грудная Хирургия 1964;5:3-8).

23. Solov'jov GM, Shumakov VI, Kuznecova VN, et al. Clinical features and diagnosis of specific complications with ball valves implanted heart. Trudy 1 Moskovskogo Meditsinskogo instituta 1967; 54: 71-4. Russian (Соловьёв Г.М., Шумаков В.И., Кузнецова В.Н. и др. Клиника и диагностика специфических осложнений с имплантированными шариковыми клапанами сердца. Труды 1 Московского Медицинского института 1967; 54: 71-4).

24. Cukerman GI, Bykova VA, Fursov BA. The first experience of the replacement of the mitral and tricuspid heart valve aortic homo- and heterotransplants. Grudnaja Hirurgia 1969;4:3-10. Russian (Цукерман Г. И., Быкова В. А., Фурсов Б. А. Первыйопыт замены митрального и трикуспидального клапанов сердца аортальными гомо- и гетеротрансплантатами. Грудная Хирургия 1969;4:3-10).

25. Dzemeshkevich SL. Bioprosthetic heart valves: the causes and pathogenesis of calcification. Biosovmestimost' 1994; 2(4): 165. (Дземешкевич С. Л. Биопротезы клапанов сердца: причины и патогенез кальцификации. Биосовместимость 1994; 2(4): 165).

26. Horstkotte D, Schulte HD, Bircks W, et al. Lower intensity anticoagulation therapy results in lower complication rates with the St Jude Medical prosthesis. J Thorac Cardiovasc Surg 1994; 107(10): 1136-45.

27. Edwards MB, Taylor KM. A profile of valve replacement surgery in the UK (1986-1997): a study from the UK Heart Valve Registry. J Heart Valve Dis 1999 ;8(6):697-701

28. Gehlot A, Mullany CJ, Ilstrup D, et al. Aortic valve replacement in patients aged eighty years and older: early and long-term results. J Thorac Cardiovasc Surg 1996;111(5):1026-36.

29. Sundt TM, Bailey MS, Moon MR, et al. Quality of life after aortic valve replacement at the age of >80 years. Circulation 2000;7;102(19 Suppl 3):III70-4.

30. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-2720

31. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8.

32. Mack MJ, Holmes DR, Webb J, et al. Patient selection for transcatheter aortic valve replacement. J Am Coll Cardiol 2013;62: S1-10.

33. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363;1597-607.

34. Kodali SK, Williams MR, Smith CR, et al. PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366(18):1686-95.

35. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve я replacement with a self-expanding prosthesis N Engl J Med 2014;370(19):1790-8.

36. Vahanian A, Baumgartner H, Bax J. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28:230-68.

37. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.

38. Akchurin RS, Komlev AE. Surgical treatment of aortic heart defects. Guide to Cardiology in 4 volumes. In: Chazov EI, editor. Moscow: Praktika; 2014: 269-80. Russian (Акчурин Р.С., Комлев А.Е. Хирургическое лечение аортальных пороков сердца. Руководство по кардиологии в 4 томах. В: Чазов Е.И., редактор. М.:Практика; 2014: 269-80).

39. Bax JJ, Delgado V, Bapat V, et al. Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. Eur Heart J 2014;35(38):2627-38.

40. Bax J.J., Delgado V., Bapat V., et al. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. Eur Heart J 2014;35(38):2639-54.

41. Jilaihawi H, Kashif M, Fontana G, et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol 2012; 59:1275-86.

42. Willson AB, Webb JG, LaBounty TM, et al. Three-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol 2012;59:1287-94.

43. Barbanti M, Yang TH, Rodès Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation 2013;128(3):244-53.

44. Khatri PJ, Webb JG, Rodes-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med 2013;158:35-46.

45. Hekimian G, Detaint D, Messika-Zeitoun D, et al. Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. J Am Soc Echocardiogr 2012;25:160-5.

46. Hahn RT, Pibarot P, Stewart WJ, et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol 2013;61:2514-21.

47. Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 2013;61:1585-95.

48. Detaint D, Lepage L, Himbert D, et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv 2009;2:821-7.

49. Linke A, Wenaweser P, Gerckens U, et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. Eur Heart J 2014;35(38):2672-84.

50. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-15.

51. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686-95.

52. Bleiziffer S, Ruge H, Mazzitelli D, et al. Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations. J Thorac Cardiovasc Surg 2009;138(5):1073-80.

53. Buellesfeld L, Wenaweser P, Gerckens U, et al. Transcatheter aortic valve implantation: predictors of procedural success-the Siegburg-Bern experience. Eur Heart J 2010;31(8):984-91.

54. Rodés-Cabau J, Dumont E, De LaRochellière R, et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 2008;102(9):1240-6.

55. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58(20):2130-8.


For citation:


Imaev T.E., Komlev A.E., Akchurin R.S. TRANSCATHETER AORTIC VALVE IMPLANTATION. STATE OF THE PROBLEM AND PROSPECTS IN RUSSIA. Rational Pharmacotherapy in Cardiology. 2015;11(1):53-59. (In Russ.) https://doi.org/10.20996/1819-6446-2015-11-1-53-59

Views: 456


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)